For TAVR patients with AFib, antiplatelet medication linked to poorer outcomes

“The rates of complications for TAVR—especially complications related to bleeding—remain high,” lead author Vincent Nijenhuis, MD, a cardiologist at St. Antonius Hospital in the Netherlands, said in a statement. “This study helps physicians to better understand the risks of adding antiplatelet therapy to oral anticoagulants—namely, that doing so…

Read the full article here

Related Articles